Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials

BACKGROUND: Sodium zirconium cyclosilicate (SZC) binds potassium and ammonium in the gastrointestinal tract. In addition to serum potassium reduction, Phase 2 trial data have shown increased serum bicarbonate with SZC, which may be clinically beneficial because maintaining serum bicarbonate ≥22 mmol...

Descripción completa

Detalles Bibliográficos
Autores principales: Roger, Simon D, Spinowitz, Bruce S, Lerma, Edgar V, Fishbane, Steven, Ash, Stephen R, Martins, Julian G, Quinn, Carol Moreno, Packham, David K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075377/
https://www.ncbi.nlm.nih.gov/pubmed/32588050
http://dx.doi.org/10.1093/ndt/gfaa158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075377/
https://www.ncbi.nlm.nih.gov/pubmed/32588050
http://dx.doi.org/10.1093/ndt/gfaa158

Ejemplares similares